Kronos Worldwide, Inc. (KRO) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Kronos Worldwide, Inc. (KRO).

Download StockRank on Google Play Download StockRank on the App Store

Equity Overview

Price & Market Data

Price: $7.64

Daily Change: +$0.05 / 0.65%

Range: $7.58 - $7.66

Market Cap: $881,175,744

Volume: 25,073

Performance Metrics

1 Week: 4.36%

1 Month: 0.92%

3 Months: -21.27%

6 Months: -34.53%

1 Year: -32.57%

YTD: -21.44%

Company Details

Employees: 2524

Sector: Process industries

Industry: Chemicals: specialty

Country: United States

Details

Kronos Worldwide, Inc. produces and markets titanium dioxide pigments (TiO2) in Europe, North America, the Asia Pacific, and internationally. The company offers TiO2 in two crystalline forms comprising rutile and anatase to impart whiteness, brightness, opacity, and durability for various products, including paints, coatings, plastics, paper, fibers, and ceramics, as well as for various specialty products, such as inks, foods, cosmetics, and pharmaceuticals. It also produces ilmenite, a raw material used directly as a feedstock by sulfate-process TiO2 plants; iron-based chemicals, which are used as treatment and conditioning agents for industrial effluents and municipal wastewater, as well as in the manufacture of iron pigments, cement, and agricultural products; and specialty chemicals for use in the formulation of pearlescent pigments, and production of electroceramic capacitors for cell phones and other electronic devices, as well as for use in natural gas pipe and other specialty applications. In addition, the company provides technical services for its products. It sells its products under the KRONOS brand through agents and distributors to paint, plastics, decorative laminate, and paper manufacturers. The company was founded in 1916 and is headquartered in Dallas, Texas. Kronos Worldwide, Inc. is a subsidiary of Valhi, Inc.

Selected stocks

Inhibikase Therapeutics, Inc. (IKT)

ProKidney Corp. (PROK)

Profound Medical Corp. (PROF)